1 Second Division, Department of Internal Medicine.
Am J Respir Cell Mol Biol. 2014 Jan;50(1):30-9. doi: 10.1165/rcmb.2013-0130OC.
IL-17A, IL-17F, and IL-25 belong to the IL-17 family of cytokines, and are well known to play important roles in the host defense against infection and inflammatory diseases. IL-17C, also a member of the IL-17 family, is highly expressed in the epithelium; however, the function and regulatory mechanism of IL-17C in airway epithelium remain poorly understood. In this study, we demonstrate that polyinosinic-polycytidylic acid (polyI:C), the ligand to Toll-like receptor 3, is a potent inducer of IL-17C mRNA and protein expression in primary normal human bronchial epithelial (NHBE) cells. IL-17C induction by polyI:C was both time dependent and dose dependent, and was attenuated by inhibitors of the Toll-IL-1 receptor domain-containing adaptor-inducing INF-β (TRIF)-NF-κB pathway, Pepinh-TRIF, BAY11, NF-κB inhibitor III, and NF-κB p65 small interfering RNA, suggesting that IL-17C expression is induced by polyI:C via the Toll-like receptor 3-TRIF-NF-κB pathway. Both IL-17C and polyI:C increased the expression of antimicrobial peptides and proinflammatory cytokines, such as human β-defensin (hBD) 2, colony-stimulating factor 3 (CSF3), and S100A12 in NHBE cells. Knockdown of IL-17 receptor (IL-17R) E, the specific receptor for IL-17C, using IL-17RE small interfering RNA, attenuated polyI:C-induced hBD2, CSF3, and S100A12 expression, without any reduction of polyI:C-induced IL-17C expression, which suggest that IL-17C enhances hBD2, CSF, and S100A12 expression in an autocrine/paracrine manner in NHBE cells. Knockdown of IL-17C also decreased polyI:C-induced hBD2, CSF3, and S100A12 expression. Thus, our data demonstrate that IL-17C is an essential epithelial cell-derived cytokine that enhances mucosal host defense responses in a unique autocrine/paracrine manner in the airway epithelium.
白细胞介素-17A(IL-17A)、白细胞介素-17F(IL-17F)和白细胞介素-25(IL-25)属于白细胞介素-17 细胞因子家族,它们在宿主抗感染和炎症性疾病的防御中起着重要作用。白细胞介素-17C 也是白细胞介素-17 细胞因子家族的成员,在上皮细胞中高度表达;然而,气道上皮细胞中白细胞介素-17C 的功能和调节机制仍知之甚少。在这项研究中,我们证明聚肌苷酸-聚胞苷酸(polyI:C),即 Toll 样受体 3 的配体,是原代正常人支气管上皮(NHBE)细胞中白细胞介素-17C mRNA 和蛋白表达的有效诱导剂。polyI:C 诱导的白细胞介素-17C 表达既具有时间依赖性又具有剂量依赖性,并被 Toll-IL-1 受体域包含衔接诱导 INF-β(TRIF)-NF-κB 途径抑制剂 Pepinh-TRIF、BAY11、NF-κB 抑制剂 III 和 NF-κB p65 小干扰 RNA 减弱,表明白细胞介素-17C 的表达是通过 Toll 样受体 3-TRIF-NF-κB 途径诱导的。白细胞介素-17C 和 polyI:C 均增加了 NHBE 细胞中抗菌肽和促炎细胞因子的表达,如人β防御素(hBD)2、集落刺激因子 3(CSF3)和 S100A12。使用白细胞介素-17RE 小干扰 RNA 敲低白细胞介素-17 受体(IL-17R)E,即白细胞介素-17C 的特异性受体,可减弱 polyI:C 诱导的 hBD2、CSF3 和 S100A12 的表达,而不减少 polyI:C 诱导的白细胞介素-17C 的表达,这表明白细胞介素-17C 以自分泌/旁分泌方式增强 NHBE 细胞中 hBD2、CSF 和 S100A12 的表达。白细胞介素-17C 的敲低也降低了 polyI:C 诱导的 hBD2、CSF3 和 S100A12 的表达。因此,我们的数据表明,白细胞介素-17C 是一种必不可少的上皮细胞衍生细胞因子,以独特的自分泌/旁分泌方式增强气道上皮细胞中的粘膜宿主防御反应。